MX2014013098A - Pirrolobenzodiacepinas. - Google Patents
Pirrolobenzodiacepinas.Info
- Publication number
- MX2014013098A MX2014013098A MX2014013098A MX2014013098A MX2014013098A MX 2014013098 A MX2014013098 A MX 2014013098A MX 2014013098 A MX2014013098 A MX 2014013098A MX 2014013098 A MX2014013098 A MX 2014013098A MX 2014013098 A MX2014013098 A MX 2014013098A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrrolobenzodiazepines
- pbds
- pyrrolobenzodiazepine
- pyrrol
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
Se encontró que pirrolobenzodiacepinas (PBDS) que tienen un residuo amino basado en (1-metil-1H-pirrol-il)fenilo son compuestos altamente efectivos que tienen citotoxicidad mejorada y propiedades de unión de ADN.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261640310P | 2012-04-30 | 2012-04-30 | |
PCT/GB2013/051098 WO2013164593A1 (en) | 2012-04-30 | 2013-04-30 | Pyrrolobenzodiazepines |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014013098A true MX2014013098A (es) | 2015-04-14 |
MX369715B MX369715B (es) | 2019-11-20 |
Family
ID=48325770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014013098A MX369715B (es) | 2012-04-30 | 2013-04-30 | Pirrolobenzodiacepinas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US9376440B2 (es) |
EP (1) | EP2855482B1 (es) |
JP (1) | JP6157596B2 (es) |
KR (1) | KR101960129B1 (es) |
CN (1) | CN104684914B (es) |
AU (1) | AU2013255613B2 (es) |
BR (1) | BR112014027143B1 (es) |
CA (1) | CA2871172C (es) |
ES (1) | ES2623042T3 (es) |
HK (1) | HK1208444A1 (es) |
IN (1) | IN2014MN02092A (es) |
MX (1) | MX369715B (es) |
NZ (1) | NZ701290A (es) |
WO (1) | WO2013164593A1 (es) |
ZA (1) | ZA201407759B (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
NZ602933A (en) | 2010-04-15 | 2014-09-26 | Seattle Genetics Inc | Pyrrolobenzodiazepines used to treat proliferative diseases |
KR101671360B1 (ko) | 2010-04-15 | 2016-11-01 | 시애틀 지네틱스, 인크. | 표적화된 피롤로벤조디아제핀 접합체 |
BR112014006703A8 (pt) | 2011-09-20 | 2018-01-09 | Spirogen Sarl | "pirrolobenzodiazepinas |
EA027386B1 (ru) | 2011-10-14 | 2017-07-31 | Медимьюн Лимитед | Пирролобензодиазепины |
EA026643B1 (ru) | 2011-10-14 | 2017-04-28 | Сиэтл Дженетикс, Инк. | Пирролбензодиазепины и конъюгаты направленного действия |
ES2945932T3 (es) | 2011-10-14 | 2023-07-10 | Seagen Inc | Pirrolobenzodiazepinas y conjugados dirigidos |
JP6170497B2 (ja) | 2011-10-14 | 2017-07-26 | メドイミューン・リミテッドMedImmune Limited | ピロロベンゾジアゼピン |
TR201902494T4 (tr) | 2012-10-12 | 2019-03-21 | Medimmune Ltd | Pirrolobenzodiazepinler ve onların konjugatları. |
JP6392763B2 (ja) | 2012-10-12 | 2018-09-19 | エイディーシー・セラピューティクス・エス・アーAdc Therapeutics Sa | ピロロベンゾジアゼピン−抗体結合体 |
SI2839860T1 (sl) | 2012-10-12 | 2019-07-31 | MedImmune Limited, | Pirolobenzodiazepini in njihovi konjugati |
US9745303B2 (en) | 2012-10-12 | 2017-08-29 | Medimmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
AU2013366490B9 (en) | 2012-12-21 | 2018-02-01 | Medimmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
EP2935268B2 (en) | 2012-12-21 | 2021-02-17 | MedImmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
SG11201507214SA (en) | 2013-03-13 | 2015-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
MX364330B (es) | 2013-03-13 | 2019-04-23 | Medimmune Ltd | Pirrolobenzodiazepinas y conjugados de las mismas. |
EP2830126B1 (en) * | 2013-05-07 | 2019-07-03 | LG Chem, Ltd. | Electrode for secondary battery, preparation thereof, and secondary battery and cable-type secondary battery comprising the same |
GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
GB201407816D0 (en) | 2014-05-02 | 2014-06-18 | King S College London | Pyrrolobenzodiazepine Compounds |
GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
CN107148285B (zh) | 2014-11-25 | 2022-01-04 | Adc治疗股份有限公司 | 吡咯并苯并二氮杂䓬-抗体缀合物 |
GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
GB201514928D0 (en) * | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
GB201521709D0 (en) * | 2015-12-09 | 2016-01-20 | Kings College London And Sec Dep For Health The | PBD Antibacterial agents |
GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
EP3458069B1 (en) | 2016-05-18 | 2023-07-05 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepines and conjugates thereof |
EP3475284B1 (en) * | 2016-06-24 | 2022-11-02 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepines and conjugates thereof |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
UA125198C2 (uk) | 2017-02-08 | 2022-01-26 | Ейдісі Терапьютікс Са | Кон'югати піролобензодіазепін-антитіло |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
US11654197B2 (en) | 2017-03-29 | 2023-05-23 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
SI3612537T1 (sl) | 2017-04-18 | 2022-10-28 | Medimmune Limited | Konjugati pirolobenzodiazepina |
CN110536703A (zh) | 2017-04-20 | 2019-12-03 | Adc治疗有限公司 | 使用抗axl抗体-药物缀合物的组合疗法 |
BR112019026564A2 (pt) | 2017-06-14 | 2020-06-30 | Adc Therapeutics Sa | regimes de dosagem para a administração de um adc anti-cd19 |
CN111065638B (zh) | 2017-08-18 | 2021-04-09 | 麦迪穆有限责任公司 | 吡咯并苯并二氮杂䓬缀合物 |
TW202405006A (zh) | 2017-09-29 | 2024-02-01 | 日商第一三共股份有限公司 | 抗體-吡咯并苯二氮呯衍生物複合體 |
WO2019104289A1 (en) | 2017-11-27 | 2019-05-31 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepine antibody conjugates |
US20220305127A1 (en) | 2017-12-21 | 2022-09-29 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepine antibody conjugates |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
KR20200084802A (ko) | 2019-01-03 | 2020-07-13 | 주식회사 레고켐 바이오사이언스 | 안전성이 향상된 피롤로벤조디아제핀 이량체 화합물 및 이의 용도 |
WO2020141923A2 (ko) | 2019-01-03 | 2020-07-09 | 주식회사 레고켐 바이오사이언스 | 안전성이 향상된 피롤로벤조디아제핀 이량체 화합물 및 이의 용도 |
GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
JP7167873B2 (ja) | 2019-07-19 | 2022-11-09 | トヨタ自動車株式会社 | 複数タイプの部品の組とハンドリング装置で構成される部品システム |
GB2597532A (en) * | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5569587A (en) | 1978-11-17 | 1980-05-26 | Meiji Seika Kaisha Ltd | Novel antibiotic neothramycin derivative and its preparation |
JPS58180487A (ja) | 1982-04-16 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 抗生物質dc−81およびその製造法 |
US5229490A (en) | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
EP0946528B1 (en) | 1996-12-23 | 2003-04-09 | Bristol-Myers Squibb Pharma Company | OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
US6187797B1 (en) | 1996-12-23 | 2001-02-13 | Dupont Pharmaceuticals Company | Phenyl-isoxazoles as factor XA Inhibitors |
WO1999046244A1 (en) | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
PT1193270E (pt) | 1998-08-27 | 2003-10-31 | Spirogen Ltd | Pirrolobenzodiazepinas |
GB9818732D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collection of compounds |
GB9818731D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
GB9818730D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collections of compounds |
US6909006B1 (en) | 1999-08-27 | 2005-06-21 | Spirogen Limited | Cyclopropylindole derivatives |
ES2276713T3 (es) | 1999-12-20 | 2007-07-01 | The University Of North Carolina At Chapel Hill | Compuesto de diamidina unidos a surcos estrechos del adn. |
US20040138269A1 (en) | 2002-10-11 | 2004-07-15 | Sugen, Inc. | Substituted pyrroles as kinase inhibitors |
GB0226593D0 (en) * | 2002-11-14 | 2002-12-24 | Consultants Ltd | Compounds |
GB0321295D0 (en) | 2003-09-11 | 2003-10-15 | Spirogen Ltd | Synthesis of protected pyrrolobenzodiazepines |
PL1720881T3 (pl) | 2004-03-01 | 2013-05-31 | Medimmune Ltd | Pochodne 11-hydroksy-5h-pirolo[2,1-c][1,4]benzodiazepin-5-onu jako kluczowe związki pośrednie do otrzymywania C2 podstawionych pirolobenzodiazepin |
GB0404577D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines |
GB0404578D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines |
GB0404574D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Amino acids |
WO2005085260A1 (en) | 2004-03-09 | 2005-09-15 | Spirogen Limited | Pyrrolobenzodiazepines |
GB0410725D0 (en) | 2004-05-13 | 2004-06-16 | Spirogen Ltd | Pyrrolobenzodiazepine therapeutic agents |
PT1879901E (pt) | 2005-04-21 | 2010-03-29 | Spirogen Ltd | Pirrolobenzodiazepinas |
ATE427949T1 (de) * | 2005-10-05 | 2009-04-15 | Spirogen Ltd | 4-a4-(5-oxo-2,3,5,11a-tetrahydro-5h-pyrrolo a2, 1-cua1,4ubenzodiazepin-8-yloxy)-butyrylaminou-1 - pyrrol-2-carbonsaurealkylesterderivate und verwandte verbindung zur behandlung einer proliferativen erkrankung |
DE102007029116A1 (de) * | 2007-06-25 | 2009-01-02 | Continental Automotive Gmbh | Verfahren zum Betreiben eines Mikrocontrollers und einer Ausführungseinheit sowie ein Mikrocontroller und eine Ausführungseinheit |
GB0722088D0 (en) * | 2007-11-09 | 2007-12-19 | Spirogen Ltd | Pyrrolobenzodiazepines |
GB0813432D0 (en) | 2008-07-22 | 2008-08-27 | Spirogen Ltd | Pyrrolobenzodiazepines |
GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
-
2013
- 2013-04-30 IN IN2092MUN2014 patent/IN2014MN02092A/en unknown
- 2013-04-30 CA CA2871172A patent/CA2871172C/en not_active Expired - Fee Related
- 2013-04-30 US US14/397,842 patent/US9376440B2/en active Active
- 2013-04-30 EP EP13721035.7A patent/EP2855482B1/en not_active Not-in-force
- 2013-04-30 WO PCT/GB2013/051098 patent/WO2013164593A1/en active Application Filing
- 2013-04-30 BR BR112014027143A patent/BR112014027143B1/pt not_active IP Right Cessation
- 2013-04-30 JP JP2015509488A patent/JP6157596B2/ja not_active Expired - Fee Related
- 2013-04-30 KR KR1020147032595A patent/KR101960129B1/ko active IP Right Grant
- 2013-04-30 NZ NZ701290A patent/NZ701290A/en not_active IP Right Cessation
- 2013-04-30 AU AU2013255613A patent/AU2013255613B2/en not_active Ceased
- 2013-04-30 MX MX2014013098A patent/MX369715B/es active IP Right Grant
- 2013-04-30 CN CN201380035167.5A patent/CN104684914B/zh not_active Expired - Fee Related
- 2013-04-30 ES ES13721035.7T patent/ES2623042T3/es active Active
-
2014
- 2014-10-24 ZA ZA2014/07759A patent/ZA201407759B/en unknown
-
2015
- 2015-09-15 HK HK15108997.9A patent/HK1208444A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2015515972A (ja) | 2015-06-04 |
BR112014027143B1 (pt) | 2020-06-09 |
IN2014MN02092A (es) | 2015-09-04 |
US9376440B2 (en) | 2016-06-28 |
CN104684914A (zh) | 2015-06-03 |
EP2855482B1 (en) | 2017-03-01 |
US20150133435A1 (en) | 2015-05-14 |
CA2871172C (en) | 2020-08-25 |
JP6157596B2 (ja) | 2017-07-05 |
HK1208444A1 (en) | 2016-03-04 |
KR101960129B1 (ko) | 2019-03-19 |
AU2013255613B2 (en) | 2017-06-22 |
NZ701290A (en) | 2016-08-26 |
KR20150016245A (ko) | 2015-02-11 |
BR112014027143A2 (pt) | 2017-06-27 |
EP2855482A1 (en) | 2015-04-08 |
MX369715B (es) | 2019-11-20 |
CA2871172A1 (en) | 2013-11-07 |
ZA201407759B (en) | 2015-11-25 |
ES2623042T3 (es) | 2017-07-10 |
WO2013164593A1 (en) | 2013-11-07 |
CN104684914B (zh) | 2017-12-15 |
AU2013255613A1 (en) | 2014-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014013098A (es) | Pirrolobenzodiacepinas. | |
HK1179953A1 (zh) | 吡咯並嘧啶化合物及其用途 | |
HUE042621T2 (hu) | Immunimprintáló táplálékkészítmény | |
SG11201401021TA (en) | Pyrrolobenzodiazepines | |
HK1189622A1 (zh) | 新的抗 抗體 | |
EP2607428A4 (en) | Resin composition | |
EP2743306A4 (en) | NETWORKED POLYETHYLENE COMPOSITION | |
PL2579859T3 (pl) | Kompozycja stała zawierająca iwabradynę | |
EP2559720A4 (en) | RETICULATED COMPOSITION | |
EP2647652A4 (en) | PHOTOCURABLE COMPOSITION | |
AP3553A (en) | Composition containing insecticide-wax particles | |
EP2613344A4 (en) | POLISHING COMPOSITION | |
EP2647672A4 (en) | RESIN COMPOSITION | |
SG11201402258UA (en) | Tricyclic compounds, compositions comprising them and uses thereof | |
ZA201308988B (en) | Palatability enhancing compositions | |
ZA201206517B (en) | Acetaminophen composition | |
EP2774029A4 (en) | PRESENTATION OF PERMITS FOR THE PRESENTATION OF CONTENT | |
EP2648517A4 (en) | TRICYCLIC HETEROCYCLES AS DIPEPTIDYLPEPTIDASE IV HEMMER | |
PL2560658T3 (pl) | Wzmacnianie cytotoksyczności komórkowej zależnej od przeciwciał | |
HK1181760A1 (zh) | 氮雜環化合物 | |
EP2762517A4 (en) | LIGHT-CURING RESIN COMPOSITION | |
EP2772505A4 (en) | LIGHT-CURABLE RESIN COMPOSITION AND NEW SILOXIDE COMPOUND | |
ZA201206841B (en) | Novel composition | |
EP2914646A4 (en) | AGGLOMERATED PRODUCT COMPOSITION | |
ZA201208412B (en) | Composition comprising cinnamon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: UCL BUSINESS PLC |
|
FG | Grant or registration |